Document:

Exhibit
10.2

 

CONFIDENTIAL
SEPARATION AGREEMENT AND GENERAL RELEASE OF ALL CLAIMS

 

This
Confidential Separation Agreement and General Release of All Claims, dated December 16, 2022 (the “Agreement”), is
entered into by and between Douglas Ross (“Employee”) on the one hand, and Oncocyte Corporation (the “Company”),
on the other. Collectively, Employee and the Company shall be referred to as the “Parties.” The Parties hereby agree
as follows:

 

1. Employee
was formerly employed by the Company. Employee’s employment with the Company ended effective December 16, 2022 (the “Termination
Date”).

 

2. The
purpose of this Agreement is to resolve any and all disputes or claims that Employee may have relating to Employee’s employment
with the Company, and the termination thereof (the “Disputes”). The parties desire to resolve the above-referenced
Disputes, and all issues raised by the Disputes, without the further expenditure of time or the expense of contested litigation. Additionally,
the Parties desire to resolve any known or unknown claims that Employee may have as more fully set forth below. For these reasons, they
have entered into this Agreement.

 

3. Employee
acknowledges and agrees that Employee has received all wages due to Employee through the Termination Date, including but not limited
to all accrued but unused vacation, bonuses, commissions, options, benefits, and monies owed by the Company to Employee. Employee further
agrees and acknowledges that Employee has been fully paid and reimbursed for any and all business expenses which Employee incurred during
his/her employment with the Company. For the avoidance of doubt, Employee is not entitled to any bonus with respect to 2022 or any other
year.

 

4. The
Company expressly denies any violation of any federal, state or local statute, ordinance, rule, regulation, policy, order or other law.
The Company also expressly denies any liability to Employee. Nothing contained herein is to be construed as an admission of liability
on the part of the Company hereby released, by whom liability is expressly denied. accordingly, while this Agreement resolves all issues
referenced herein, it does not constitute an adjudication or finding on the merits of the allegations in the disputes and it is not,
and shall not be construed as, an admission by the Company of any violation of federal, state or local statute, ordinance, rule, regulation,
policy, order or other law, or of any liability alleged in the disputes.

 

5. In
consideration of and in return for the promises and covenants undertaken by the Company and Employee herein and the releases given by
Employee herein, and in exchange for Employee timely executing (and not revoking) this Agreement:

 

a. In
addition to any compensation otherwise due Employee for actual work performed up to and including the Termination Date, Employee shall
receive the following benefits:

 

(i) A
payment in the total amount of Two Hundred Eighty One Thousand Two Hundred and Fifty Dollars and Six Cents ($281,250.06) (minus applicable
taxes, withholdings and deductions), payable in substantially equal installments over the nine (9) month period following the Termination
Date in accordance with the Company’s regular payroll practices; provided, however, that the first payment shall be made on the
first regularly scheduled payroll date on or following the thirtieth (30th) day following the Termination Date and shall include payments
of any amounts that would otherwise be due prior thereto; and

 

    	1

     

    

 

(ii) A
payment for nine (9) months of premium costs of group health plan continuation coverage under the Consolidated Omnibus Budget Reconciliation
Act in the total amount of $20,799 (minus applicable taxes, withholdings and deductions), payable in substantially equal installments
over the nine (9) month period following the Termination Date in accordance with the Company’s regular payroll practices; provided,
however, that the first payment shall be made on the first regularly scheduled payroll date on or following the thirtieth (30th) day
following the Termination Date and shall include payments of any amounts that would otherwise be due prior thereto.

 

As
a condition to receiving and continuing to receive the payments and benefits under this Paragraph 5.a., Employee must (i) within but
not later than twenty-one (21) days after the Termination Date, execute (and not revoke) and deliver to the Company this Agreement and
(ii) remain in full compliance with this Agreement and the Surviving Provisions (as defined below). Employee shall not be entitled to
accrue any additional leave or other benefits subsequent to the Termination Date.

 

b. Any
tax liabilities resulting from or arising out of the benefits to Employee referred to above shall be the sole and exclusive responsibility
of Employee. Employee agrees to indemnify and hold the Company and the others released herein harmless from and for any tax liability
(including, but not limited to, assessments, interest, and penalties) imposed on the Company by any taxing authority on account of the
Company failing to withhold for tax purposes any amount from the benefits made as consideration of this Agreement.

 

c. Employee
acknowledges and agrees that (i) any equity granted pursuant to the Company’s Amended and Restate 2018 Equity Incentive Plan (the
“Equity Plan”) that is unvested as of the Termination Date, shall automatically be forfeited as of the Termination
Date for no consideration and (ii) any equity that is vested as of the Termination Date shall be subject to the terms and conditions
of the Equity Plan and applicable award agreement(s).

 

6. Except
for any rights created by this Agreement, in consideration of and in return for the promises and covenants undertaken herein by the Company,
and for other good and valuable consideration, receipt of which is hereby acknowledged:

 

a. Employee
does hereby acknowledge full and complete satisfaction of and does hereby release, absolve and discharge the Company, and each of its
parents, subsidiaries, divisions, related companies and business concerns, past and present, as well as each of its partners, trustees,
directors, members, officers, agents, attorneys, servants and employees, past and present, and each of them (hereinafter collectively
referred to as “Releasees”) from any and all claims, demands, liens, agreements, contracts, covenants, actions, suits,
causes of action, grievances, wages, vacation payments, severance payments, obligations, commissions, overtime payments, debts, profit
sharing claims, expenses, damages, judgments, orders and liabilities of whatever kind or nature in law, equity or otherwise, whether
known or unknown to Employee which Employee now owns or holds or has at any time owned or held as against Releasees, or any of them,
including specifically but not exclusively and without limiting the generality of the foregoing, any and all claims, demands, grievances,
agreements, obligations and causes of action, known or unknown, suspected or unsuspected by Employee: (1) arising out of or in any way
connected with the Disputes; or (2) arising out of Employee’s employment (or termination thereof) with the Company (including,
but not limited to, under Employee’s Employment Agreement with the Company, dated as of March 23, 2020, as amended May 7, 2020
(the “Employment Agreement”) and that certain Change in Control and Severance Agreement between the Employee and the
Company effective March 1, 2020 (the “Severance Agreement”)); or (3) arising out of or in any way connected with any
claim, loss, damage or injury whatever, known or unknown, suspected or unsuspected, resulting from any act or omission by or on the part
of the Releasees, or any of them, committed or omitted on or before the Effective Date hereof. Additionally, Employee in any future claims
may not use against Releasees as evidence any acts or omissions by or on the part of the Releasees, or any of them, committed or omitted
on or before the Effective Date hereof, and no such future claims may be based on any such acts or omissions. Also without limiting the
generality of the foregoing, Employee specifically releases the Releasees from any claim for attorneys’ fees. EMPLOYEE ALSO SPECIFICALLY
AGREES AND ACKNOWLEDGES EMPLOYEE IS WAIVING ANY RIGHT TO RECOVERY BASED ON LOCAL, STATE OR FEDERAL EMPLOYMENT LAWS OR REGULATIONS, OR
ANY LOCAL, STATE, OR FEDERAL AGE, SEX, PREGNANCY, RACE, COLOR, NATIONAL ORIGIN, MARITAL STATUS, RELIGION, VETERAN STATUS, DISABILITY,
SEXUAL ORIENTATION, MEDICAL CONDITION OR OTHER ANTI-DISCRIMINATION LAWS, INCLUDING, WITHOUT LIMITATION, TITLE VII OF THE CIVIL RIGHTS
ACT OF 1964, THE AGE DISCRIMINATION IN EMPLOYMENT ACT, THE EQUAL PAY ACT, THE AMERICANS WITH DISABILITIES ACT, THE FAMILY AND MEDICAL
LEAVE ACT, THE EMPLOYEE RETIREMENT INCOME SECURITY ACT, THE WORKER ADJUSTMENT AND RETRAINING ACT, THE FAIR LABOR STANDARDS ACT, AND ANY
OTHER SECTION OF THE CALIFORNIA LABOR OR GOVERNMENT CODE, THE INDUSTRIAL WELFARE COMMISSION WAGE ORDERS, ALL AS AMENDED, WHETHER SUCH
CLAIM BE BASED UPON AN ACTION FILED BY EMPLOYEE OR BY A GOVERNMENTAL AGENCY. This release does not release claims that cannot be released
as a matter of law. Employee is not (i) waiving Employee’s right to file a charge, testify, assist, or cooperate with the Equal
Employment Opportunity Commission (EEOC), Department of Fair Employment and Housing (DFEH) or similar governmental agency, (ii) waiving
rights or claims that may arise after the date Employee signs this Agreement, or (iii) releasing claims for unemployment compensation
benefits, workers’ compensation benefits, those claims under the Fair Labor Standards Act which cannot be waived pre-litigation
without Department of Labor or court approval, health insurance benefits under the Consolidated Omnibus Budget Reconciliation Act (COBRA),
or claims with regard to vested benefits under a retirement plan governed by the Employee Retirement Income Security Act (ERISA).

 

    	2

     

    

 

7. Employee
agrees and understands as follows: it is the intention of Employee in executing this instrument that it shall be effective as a bar to
each and every claim, demand, grievance and cause of action hereinabove specified. In furtherance of this intention, Employee hereby
expressly waives any and all rights and benefits conferred upon Employee by the provisions of section 1542 of the California Civil Code
(or any other similar state code) and expressly consents that this Agreement shall be given full force and effect according to each and
all of its express terms and provisions, including those relating to unknown and unsuspected claims, demands and causes of action, if
any, as well as those relating to any other claims, demands and causes of action hereinabove specified. Section 1542 provides:

 

A
general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor
at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the
debtor or released party.

 

Having
been so apprised, Employee nevertheless hereby voluntarily elects to and does waive the rights described in Civil Code section 1542 and
elects to assume all risks for claims that now exist in Employee’s favor, known or unknown, that are released under this Agreement.

 

8. Employee
acknowledges and agrees that (a) the following Sections of the Employment Agreement remain in full force and effect and will continue
to bind Employee following the Termination Date in accordance with their terms: Section 3 (Competitive Activities), Section 4 (Inventions/Intellectual
Property/Confidential Information), Section 6 (Turnover of Property and Documents on Termination), Section 7 (Resignation as a Director
on Termination of Employment), Section 8 (Arbitration), Section 9 (Severability), Section 10 (Agreement Read and Understood), Section
11 (Complete Agreement, Modification), Section 12 (Governing Law), Section 13 (Assignability), Section 14 (Survival), and Section 15
(Notices), (b) the entirety of the Employee Confidential Information and Inventions Assignment Agreement by and between the Employee
and the Company, effective March 16, 2020 shall remain in full force and effect and will continue to bind Employee following the Termination
Date in accordance with its terms, and (c) Section 3.6 (Covenants) of the Severance Agreement will continue to bind Employee following
the Termination Date in accordance with its term (collectively, all of the foregoing, the “Surviving Provisions”).
Any disputes arising under this Agreement, under the Surviving Provisions, or otherwise arising between Employee, on the one hand, and
any of the Releasees, on the other hand, shall be resolved in accordance with the dispute resolution terms provided in Section 8 of the
Employment Agreement.

 

9. Employee
acknowledges and agrees that as of Employee’s Termination Date Employee will automatically be deemed to have resigned from the
Board and from any and all other positions and/or titles with the Company and agrees to execute any and all documentation the Company
requests to effectuate the foregoing.

 

10. In
the event a government agency files or pursues a charge or complaint relating to Employee’s employment with the Company and/or
the disputes, Employee agrees not to accept any monetary or other benefits arising out of the charge or complaint.

 

11. Employee
agrees that Employee will not, whether in private or in public, whether orally or in writing, directly or indirectly, in public or in
private, make, publish, encourage, ratify, or authorize, or aid, assist, encourage, or direct any other person or entity in making or
publishing, any statements that in any way (i) defame, malign, disparage, or impugn the character, integrity, or ethics of the Releasees
(ii) portray any of the Releasees in a negative light, or (iii) damage the image or reputation of any of the Releasees. For avoidance
of doubt, nothing in this Paragraph 11 shall be construed in a manner that would violate any law. The Company agrees that it will instruct
its senior executives and board members not to make or publish negative or disparaging remarks that in any way relate to Employee. Nothing
in this Agreement prevents Employee from discussing or disclosing information about unlawful acts in the workplace, such as harassment
or discrimination or any other conduct that Employee has reason to believe is unlawful.

 

    	3

     

    

 

12. If
any provision of this Agreement or application thereof is held invalid, the invalidity shall not affect other provisions or applications
of the Agreement which can be given effect without the invalid provision or application. To this end, the provisions of this Agreement
are severable.

 

13. Employee
agrees and understands that this Agreement may be treated as a complete defense to any legal, equitable, or administrative action that
may be brought, instituted, or taken by Employee, or on Employee’s behalf, against the Company or the Releasees, and shall forever
be a complete bar to the commencement or prosecution of any claim, demand, lawsuit, charge, or other legal proceeding of any kind against
the Company and the Releasees.

 

14. This
Agreement and all covenants and releases set forth herein shall be binding upon and shall inure to the benefit of the respective Parties
hereto, their legal successors, heirs, assigns, partners, representatives, parent companies, subsidiary companies, agents, attorneys,
officers, employees, directors and stockholders.

 

15. The
Parties hereto acknowledge each has read this Agreement, that each fully understands its rights, privileges and duties under the Agreement,
that each has had an opportunity to consult with an attorney of its choice and that each enters this Agreement freely and voluntarily.

 

16. This
Agreement may not be released, discharged, abandoned, changed or modified in any manner, except by an instrument in writing signed by
Employee and an officer of the Company. The failure of any party to enforce at any time any of the provisions of this Agreement shall
in no way be construed as a waiver of any such provision, nor in any way to affect the validity of this Agreement or any part thereof
or the right of any party thereafter to enforce each and every such provision. No waiver of any breach of this Agreement shall be held
to be a waiver of any other or subsequent breach.

 

17. This
Agreement and the provisions contained herein shall not be construed or interpreted for or against any party hereto because that party
drafted or caused that party’s legal representative to draft any of its provisions.

 

18. Employee
acknowledges Employee may hereafter discover facts different from, or in addition to, those Employee now knows or believes to be true
with respect to the claims, demands, liens, agreements, contracts, covenants, actions, suits, causes of action, wages, obligations, debts,
expenses, damages, judgments, orders and liabilities herein released, and agrees the release herein shall be and remain in effect in
all respects as a complete and general release as to all matters released herein, notwithstanding any such different or additional facts.

 

    	4

     

    

 

19. The
undersigned each acknowledge and represent that no promise or representation not contained in this Agreement has been made to them and
acknowledge and represent that this Agreement and the Severance Agreement contains the entire understanding between the parties and contains
all terms and conditions pertaining to the compromise and settlement of the subjects referenced herein. The undersigned further acknowledge
that the terms of this Agreement are contractual and not a mere recital.

 

20. Employee
expressly acknowledges, understands and agrees that this Agreement includes a release covering all legal rights or claims under the Age
Discrimination in Employment Act of 1967 (29 U.S.C. § 626, as amended), and all other federal, state, and local laws regarding age
discrimination, whether those claims are presently known to Employee or hereafter discovered. The terms and conditions of Paragraphs
20 through 22 apply to and are part of the waiver and release of ADEA claims under this Agreement. Company hereby advises Employee in
writing to discuss this Agreement with an attorney before signing. Employee acknowledges the Company has provided Employee at least twenty-one
(21) days within which to review and consider this Agreement before signing it. If Employee elects not to use all twenty-one
(21) days, then Employee knowingly and voluntarily waives any claim that Employee was not in fact given that period of time or did not
use the entire twenty-one (21) days to consult an attorney and/or consider this Agreement.

 

21. Within
three (3) calendar days of signing and dating this Agreement, Employee shall deliver the signed original of this Agreement
to the General Counsel of the Company. However, the Parties acknowledge and agree that Employee may revoke this Agreement for up to seven
(7) calendar days following Employee’s execution of this Agreement and that it shall not become effective or enforceable
until the revocation period has expired. The Parties further acknowledge and agree that such revocation must be in writing addressed
to and received by the General Counsel of the Company not later than midnight on the seventh day following execution of this Agreement
by Employee. If Employee fails to timely execute this Agreement or revokes this Agreement under this Paragraph, this Agreement shall
not be effective or enforceable and Employee will not receive the benefits described above, including those described in paragraph 5.

 

22. If
Employee does not revoke this Agreement in the timeframe specified at Paragraph 21 above, the Agreement shall be effective at 12:00:01
a.m. on the eighth day after it is signed by Employee (the “Effective Date”).

 

23. This
Agreement is intended to be exempt from the requirements of section 409A of the Internal Revenue Code of 1986, as amended, and the rules
and regulations promulgated thereunder (“Section 409A”) and will be interpreted accordingly. While it is intended
that all payments and benefits provided under this Agreement to Employee or on behalf of Employee will be exempt from Section 409A, the
Company makes no representation or covenant to ensure that such payments and benefits are exempt from or compliant with Section 409A.
The Company will have no liability to Employee or any other party if a payment or benefit under this Agreement is challenged by any taxing
authority or is ultimately determined not to be exempt from or compliant with Section 409A. Each payment made under this Agreement will
be treated as a separate payment for purposes of Section 409A and the right to a series of installment payments under this Agreement
is to be treated as a right to a series of separate payments.

 

    	5

     

    

 

24. This
Agreement may be executed in any number of counterparts, each of which so executed shall be deemed to be an original, and such counterparts
shall together constitute one and the same Agreement.

 

25. This
Agreement shall be construed in accordance with, and be deemed governed by the laws of the State of California, without reference to
the conflict of law provisions thereof.

 

26. The
Company executes this Agreement for itself and on behalf of all other respective Releasees.

 

Employee
has read the foregoing Confidential Separation Agreement and General Release of All Claims, and Employee accepts and agrees to the provisions
contained therein and hereby executes it voluntarily and with full understanding of its consequences.

 

PLEASE
READ CAREFULLY. THIS AGREEMENT CONTAINS A GENERAL

RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS.

 

    	6

     

    

 

	Dated:	12/19/2022
	 	/s/
                                            Douglas Ross

	 	 	 	Douglas
                   Ross
	 	 	 	 
	 	 	 	Oncocyte
                                            Corporation
	 	 	 	 
	Dated:	12/19/2022	 	/s/
                                            Andy Arno
 
	 	 	 	Name:	Andy
                   Arno
	 	 	 	Title:	Chairman
                   of the Board of Directors

 

Signature
Page to Confidential Separation Agreement and General Release of All Claims – Douglas RossExhibit
10.3

 

CONSULTING
AGREEMENT

 

THIS
CONSULTING AGREEMENT (this “Agreement”), dated as of December 16, 2022 is hereby entered into by and between OncoCyte
Corporation (the “Company”) and Douglas Ross (the “Consultant” and, collectively with the Company,
the “Parties”).

 

In
consideration of the mutual covenants and promises contained herein, and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged by the Parties, the Parties agree as follows:

 

1.
 Engagement. The Consultant is being engaged by the Company as an independent contractor
commencing on December 17, 2022 (the “Commencement Date”) and continuing until March 31, 2023, unless terminated earlier
pursuant to Section 11 below (the “Consulting Term”). The term of this Agreement may be extended by the mutual written
and duly executed agreement of the Parties.

 

2.
 Services. The services hereunder are set forth in Appendix A hereto (collectively,
the “Consulting Services”). During the Consulting Term, the Consultant shall perform the Consulting Services remotely
from Consultant’s office in California, unless otherwise requested by the Chairman of the Board of Directors (the “Board”)
or his or her designee. The Company liaison who shall be the point of contact for the Consultant while the Consultant performs the Consulting
Services will be the Chairman of the Board or his or her designee.

 

3.
 Independent Contractor.

 

(a) The
Parties agree that the Consultant will be an independent contractor of the Company. The Consultant shall perform the Consulting Services
utilizing Consultant’s own tools, equipment, means and manner. Nothing in this Agreement is intended to, or shall be deemed to,
create any partnership, agency, or joint venture relationship between or among the Consultant or any of Consultant’s employees,
agents, or subcontractors (collectively, with the Consultant, the “Consultant Parties”), on the one hand, and the
Company or any of the Company Parties (as defined below), on the other hand.

 

(b) Neither
the Consultant nor any of the other Consultant Parties is eligible for or will receive any of the rights, privileges, interests, benefits,
or perquisites that the Company extends to its employees, including, but not limited to, any wages, compensation, commissions, bonuses,
profit sharing benefits, carried interest, equity, phantom equity, performance compensation, pension benefits, savings benefits, 401(k)
benefits, vacation, sick pay, or severance benefits, even if Consultant or any Consultant Party is deemed an employee of the Company
by any agency, arbitrator, or tribunal. The Consultant and the Consultant Parties will not participate in any of the plans or programs
that the Company makes available to its employees and hereby reject and release any and all right, claim, or interest to any and all
payments, compensation, rights, privileges, benefits, and/or perquisites from any of the Company Parties.

 

4.
 Consulting Fee and Related Matters.

 

(a) Consulting
Fee: The Company will compensate the Consultant by granting Consultant restricted stock units pursuant to the Company’s 2018
Equity Incentive Plan, as amended from time to time (the “Plan”), with a grant date fair market value of $56,250 (as
determined in accordance with the Plan) (such restricted stock units, the “Consulting RSUs”). The Consulting RSUs
shall be granted on the third (3rd) business day following the Commencement Date and shall vest as to one-third of the Consulting RSUs
on each January 31, 2022, February 28, 2023 and March 31, 2023, subject to the Consultants continued compliance with any restrictive
covenants by which the Consultant may be bound and continuous provision of Consulting Services under this Agreement on each applicable
vesting date, except as otherwise provided in Section 11, and shall be subject to such other terms and conditions as determined by the
Board.

 

    	1

     

    

 

(b) Consulting
Expenses. During the Consulting Term, the Company shall reimburse the Consultant for ordinary and necessary out-of-pocket and documented
business expenses incurred by the Consultant in the performance of duties for the Company in accordance with the Company’s usual
policies in effect from time to time and upon the receipt by the Company of satisfactory written substantiation of such expenses; provided,
however, that any expense exceeding $100 shall require pre-approval by the Chairman of the Board or his or her designee.

 

(c) Consultant
Party Compensation/Taxes/Benefits. The Consultant shall bear sole responsibility for any and all wages and other compensation due
to Consultant and/or any Consultant Party. The Consultant shall also bear sole responsibility for all federal, state, and local income
tax withholding, social security taxes, workers’ compensation coverage, unemployment insurance, liability insurance, health and/or
disability insurance, retirement benefits, health and welfare benefits, pension benefits, other payments or expenses due or owed to,
for, or with respect to any Consultant Party. Consultant and the Consultant Parties shall, jointly and severally, indemnify and hold
harmless the Company and each of the Company Parties from and against any and all taxes or other liability (including interest, penalties,
accountants’ and attorneys’ fees, costs, and expenses) which may be assessed, imposed, or incurred as a result of or relating
to this Agreement or any amounts received by Consultant or the Consultant Parties from the Company or the Company Parties. In the event
the Company or any of the Company Parties is required to make any payments (i) that are Consultant’s obligations under this Agreement,
or (ii) to the Internal Revenue Service or any other taxing authority in respect of any taxes (other than withholding), Consultant shall,
upon receipt of written notice from the Company, remit to the Company an amount equal to such payments, within ten (10) business days
from such notice.

 

(d)Insurance.The
Consultant shall carry appropriate insurance in connection with the Consulting Services, naming the Company and its affiliates and their
respective officers, directors, and employees as additional insureds, and shall, upon request, furnish the Company with a certificate
of insurance verifying such coverage.

 

5.
 Company Protections.

 

(a) During
the Consultant’s engagement as an independent contractor performing the Consulting Services for the Company, the Consultant Parties
may have access to or otherwise become familiar with certain Confidential Information (as defined below) that is proprietary to the Company
Parties and/or provides the Company Parties with a crucial competitive advantage. Consultant agrees that the Consultant and the Consultant
Parties will not divulge, use, publish, or in any other manner reveal any Confidential Information except (x) during Consultant’s
engagement with the Company as required for, and to the extent authorized by the Company, in furtherance of the proper performance of
the Consulting Services, or (y) as discussed with, and approved in writing by the Company. For purposes of this Agreement, “Confidential
Information” includes any and all non-public information, confidential information, proprietary information, trade secrets,
or other information (whether oral or written, whether maintained in hard copy, electronically, or otherwise) regarding the business
or affairs of the Company Parties, including, without limitation, (i) trade secrets, inventions, algorithms, mask works, ideas, processes,
formulas, software in source or object code, data, programs, other works of authorship, know-how, improvements, discoveries, developments,
designs and techniques and any other proprietary technology and all intellectual property rights, and genetic and protein biomarkers
of any and all kinds used in or related to Company diagnostic tests, products, or research, even if not patented or patentable; (ii)
information regarding research, development, new products, marketing and selling, business plans, budgets and unpublished financial statements,
licenses, prices and costs, margins, discounts, credit terms, pricing and billing policies, quoting procedures, methods of obtaining
business, forecasts, future plans and potential strategies, financial projections and business strategies, operational plans, financing
and capital-raising plans, activities and agreements, internal services and operational manuals, methods of conducting Company business,
suppliers and supplier information, and purchasing; (iii) information regarding customers and potential customers of Company, including
customer lists, names, representatives, their needs or desires with respect to the types of products or services offered by Company,
proposals, bids, contracts and their contents and parties, the type and quantity of products and services provided or sought to be provided
to customers and potential customers of Company and other non-public information relating to customers and potential customers; (iv)
information regarding any of Company’s business partners and their services, including names, representatives, proposals, bids,
contracts and their contents and parties, the type and quantity of products and services received by Company, and other non-public information
relating to business partners; (v) information regarding personnel, employee lists, compensation, and employee skills; and (vi) any other
non-public information which a competitor of Company could use to the competitive disadvantage of Company. For purposes of this Agreement,
(i) the “Company Entities” means Company and each and all of Company’s respective affiliates and subsidiaries,
and including each and all of their respective advisory, management, and partner entities and/or funds and any successor or permitted
transferee of any of the foregoing; and (ii) the “Company Parties” means, collectively, each and all of the Company
Entities and each and all of their respective current and former shareholders, interest holders, unit holders, advisors, managers, officers,
directors, partners, principals, members, employees, fiduciaries, representatives, and agents.

 

    	2

     

    

 

(b) Upon
ceasing to perform the Consulting Services for the Company, or at any other time requested by the Company, the Consultant Parties shall
return all Company Confidential Information, documents, or other Company property.

 

(c) Except
as provided in Section 5(d), below, the Consultant Parties agree that in the event they are served with a subpoena, document request,
information request, interrogatory, or any other legal process (i) that will or may require any Consultant Party to disclose any Confidential
Information, or (ii) relating to the Company Parties, the Consultant will immediately notify the Chairman of the Board of such fact,
in writing, and provide a copy of such subpoena, document request, interrogatory, or other legal process. The Consultant Parties further
agree to cooperate with the Company in any lawful response to such subpoena, document request, information request, interrogatory, or
legal process.

 

(d) In
accordance with the Defend Trade Secrets Act, 18 U.S.C. § 1833(b), and other applicable law, nothing in this Agreement, any other
agreement, or any Company policy shall prevent the Consultant Parties from, or expose the Consultant Parties to criminal or civil liability
under foreign, or U.S. federal or state trade secrets law for, (i) directly or indirectly sharing any trade secrets, Confidential Information,
or other information (except information protected by the Company’s attorney-client or work product privilege) with an attorney,
law enforcement, or with any foreign, federal, state, or local governmental agency, official, or entity (including the Department of
Justice, the Securities and Exchange Commission, the Equal Employment Opportunity Commission, any analogous state or local agencies,
the Congress, and any agency Inspector General), for the purpose of reporting, investigating, complaining about, or cooperating with
respect to a suspected violation of law (including any whistleblower retaliation claim), whether in response to a subpoena or otherwise,
without notice to the Company, or (ii) disclosing trade secrets in a complaint or other document filed in an arbitration, lawsuit, or
other proceeding (including any whistleblower retaliation claim), provided that the filing is made under seal.

 

(e) Consultant
acknowledges and agrees that Consultant is bound by certain restrictive covenants pursuant to the Confidential Separation Agreement and
General Release of All Claims by and between Consultant and the Company, dated December 1, 2022, and that nothing contained herein shall
be deemed to abrogate such obligations.

 

    	3

     

    

 

6.
 Compliance with Law. In rendering the Consulting Services, the Consultant Parties will
comply with all applicable laws, rules, and regulations, including but not limited to any applicable standards governing the collection,
use, storage, and disclosure of information. The Consultant Parties represent that they will maintain appropriate controls and procedures
to ensure the Consultant Parties’ compliance with the foregoing. The Consultant Parties assume full responsibility for complying
with (x) any registration, licensing or other relevant laws affecting the Consulting Services to be provided by the Consultant Parties,
and possesses all the required licenses, registrations and authorizations in each relevant jurisdiction and with respect to the Consulting
Services, and (y) any applicable immigration laws or other laws regarding any lawful authorization required to perform the Consulting
Services, and possess all required authorizations in each relevant jurisdiction with respect to the same.

 

7.
 No Authority. The Consultant acknowledges and agrees that the Consultant Parties do
not have authority to act on behalf of, or otherwise bind, any of the Company Parties. Accordingly, the Consultant Parties may not enter
into any agreements on behalf of or purport to bind any Company Party, or represent to any person or entity that any Consultant Party
has the power to create any obligation, express or implied, on behalf of any Company Party without the Company’s express prior
written consent. The Consultant Parties also acknowledge and agree that the Consultant Parties do not have investment discretion or any
authority to enter into agreements with respect to any accounts or assets, nor do they exercise any voting or other rights or privileges
associated with the ownership of such accounts or assets.

 

8.
 Intellectual Property. The Consultant Parties agree that the Company is the exclusive
owner of all discoveries, developments, intellectual property, inventions (whether or not patentable), methods, processes, trade secrets,
trademarks, domain names, computer programs and code (including source code and object code), research, original works of authorship,
writings, or other work product invented, conceived, developed, authored, reduced to practice, or otherwise made (collectively, “Created”)
by the Consultant Parties, whether individually or jointly with others, whether in whole or in part in connection with the Consultant
Parties’ performance of the Consulting Services or on the Company’s time or with the use of the Company Parties’ information,
resources, or materials (collectively, “Developments”), and the Consultant Parties hereby assign any and all right,
title, and interest in and to such Developments, including the intellectual property rights therein, to the Company, effective automatically
as and when each such Development is Created. For the avoidance of doubt, any copyrightable subject matter embodied in any Development
will be considered a “work made for hire” within the meaning of the copyright laws of the United States of America (17 U.S.C.
§ 101 et seq.) with initial ownership of such subject matter vesting in the Company. To the extent any Development is not deemed
a “work made for hire,” or to the extent that the Company would not otherwise automatically own any and all Developments,
including all intellectual property rights therein, the Consultant Parties hereby assign all right, title, and interest in and to such
Developments, including the intellectual property rights therein, to the Company, effective automatically as and when each such Development
is Created. The Company shall have the full worldwide right to use, assign, license and/or transfer all rights in, with, to, or relating
to any and all Developments (and all intellectual property rights therein). Whenever requested to do so by the Company (whether during
the Consulting Term or thereafter), the Consultant Parties will execute any instruments, and do all other things that the Company deems
necessary or appropriate to evidence, confirm, or give effect to the foregoing assignment or to apply for and obtain patents or trademark
or copyright registrations, or to otherwise protect the Company’s interest therein (without additional compensation to the Consultant).

 

    	4

     

    

 

9.
 Arbitration. It is the intention of Consultant and Company that the Federal Arbitration
Act and the California Arbitration Act shall apply with respect to the arbitration of disputes, claims, and controversies pursuant to,
arising under, or in connection with this Agreement. Except for injunctive proceedings against unauthorized disclosure of confidential
information or other actual or threatened breach of this Agreement that may cause irreparable and continuing injury to the Company or
its subsidiaries or affiliates for which there is no adequate remedy at law (and upon the issuance or denial of an injunction the underlying
merits of any dispute will be resolved in accordance with the remainder of this Section), any and all claims or controversies between
Company or any Subsidiary and Consultant, including but not limited to (a) those involving the construction or application of any of
the terms, provisions, or conditions of this Agreement or the Policies; (b) all contract or tort claims of any kind; and (c) any claim
based on any federal, state, or local law, statute, regulation, or ordinance, shall be settled by arbitration in accordance with the
then current Commercial Dispute Resolution Rules of the American Arbitration Association (“AAA”) or the Commercial Arbitration
Rules & Procedures of the Judicial Arbitration and Mediation Service (“JAMS”), as selected by Company or a Subsidiary.
Judgment on the award rendered by the arbitrator(s) may be entered by any court having jurisdiction over Company and Consultant. The
location of the arbitration shall be San Francisco, California. Unless Company or a Subsidiary and Consultant mutually agree otherwise,
the arbitrator shall be a retired judge selected from a panel provided by the AAA or JAMS. Company, or a Subsidiary, if the Subsidiary
is a party to the arbitration proceeding, shall pay the arbitrator’s fees and costs. Consultant shall pay for Consultant’s
own costs and attorneys’ fees, if any. Company and any Subsidiary that is a party to an arbitration proceeding shall pay for its
own costs and attorneys’ fees, if any. However, if any party prevails on a statutory claim which affords the prevailing party attorneys’
fees, the arbitrator may award reasonable attorneys’ fees and costs to the prevailing party. CONSULTANT UNDERSTANDS AND AGREES
THAT THIS AGREEMENT TO ARBITRATE CONSTITUTES A WAIVER OF CONSULTANT’S RIGHT TO A TRIAL BY JURY OF ANY MATTERS COVERED BY THIS AGREEMENT
TO ARBITRATE. Nothing in this Section shall be construed in a manner that would violate any law.

 

10. Warranties

 

(a) The
Consultant Parties warrant that their performance of the Consulting Services will not violate (i) any applicable law, rule, or regulation;
(ii) any contracts with any third-parties, or (iii) any third-party rights in any patent, trademark, service mark, trade name, copyright,
trade secret, or other property. The Consultant Parties further warrant that they are the lawful owners or licensees of any software
programs or other materials used by the Consultant Parties in the performance of the Consulting Services and that the Consultant Parties
have all rights necessary to convey to the Company the unencumbered ownership of any Developments, work product, and/or other deliverables.

 

(b) The
Consultant Parties hereby represent and warrant that they are not currently engaged, nor will they engage during the term of this Agreement
hereunder, in or on any other project or matter (including, without limitation, the provision of similar services to parties other than
the Company) that might reasonably be construed to be in conflict with the Consulting Services.

 

    	5

     

    

 

11. Termination.

 

(a) Either
the Consultant or the Company may terminate the Consulting Services at any time by giving the other Party at least ten (10) days’
prior written notice.

 

(b) If
the Consulting Services are terminated by the Company prior to March 31, 2023, subject to Consultant’s continued compliance with
any restrictive covenants by which the Consultant may be bound, the Consulting RSUs shall automatically vest and become exercisable as
of the termination date, which shall satisfy all of the Company’s obligations to the Consultant. If the Consulting Services are
terminated by the Consultant prior to March 31, 2023, (x) the Consultant shall retain any Consulting RSUs that are vested as of the termination
date and (y) the Consultant shall automatically forfeit the Consulting RSUs that are unvested as of the termination date for no consideration,
which shall satisfy all of the Company’s obligations to the Consultant. The retained vested Consulting RSUs shall remain subject
to the terms and conditions of the Equity Plan and applicable award agreement.

 

12. Miscellaneous.

 

(a) Entire
Agreement. Except as provided in Section 5(e), this Agreement constitutes the entire agreement of the Parties and replaces and supersedes
any prior agreements, understandings, or arrangements between any of the Company Parties, on the one hand, and any of the Consultant
Parties, on the other hand with respect to the subject matters contained herein.

 

(b) Amendment;
Waiver. This Agreement may not be amended, altered, waived, or superseded except by a written an instrument signed by the Consultant
and another of the Company. A waiver of any breach of this Agreement, or the failure to enforce any term or provision of this Agreement,
shall not in any way affect, limit, or waive a Party’s rights to fully enforce the same or any other term or provision of this
Agreement in the future.

 

(c) Successors
and Assigns. The Consultant will not assign, transfer, or subcontract this Agreement or any of the Consultant’s obligations
hereunder without the prior written consent of the Company. This Agreement shall inure to the benefit of the successors and assigns of
the Company, and the Company may, without Consultant’s prior consent, assign its rights and obligations under this Agreement or
any part hereof to one or more of the Company Parties or as otherwise permitted by law, or assign this Agreement in its entirety to a
successor to all or substantially all of its business or assets to which this Agreement relates.

 

(d) Governing
Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of California, regardless of the
laws that might otherwise govern under applicable principles of conflicts of law.

 

(e) Notices.
All notices, demands and other communications hereunder shall be in writing and shall be given both by email and by overnight delivery
(either FedEx or UPS) as follows: (i) in the case of the Consultant, to the last address and/or email address on file with the Company
and (ii) in the case of the Company, to its executive offices, attention to the General Counsel or, in each case, to such other address,
and with such other copies, as either Party may hereafter specify in writing in accordance with this Section 12(e) for the purpose of
receiving notice. Each such notice or other communication shall be effective at the time so indicated by the confirmation of delivery
provided by UPS or FedEx.

 

(f) Severability.
If any provision or clause of this Agreement is found to be invalid or unenforceable under any applicable law, this Agreement shall be
considered severable and divisible, and an arbitrator or reviewing court shall have the authority to “blue pencil” or otherwise
modify this Agreement so as to make it fully valid and enforceable while enforcing the original intent of the parties, as reflected herein,
to the maximum extent possible.

 

(g) Construction.
This Agreement shall be interpreted strictly in accordance with its terms, to the maximum extent permissible under governing law, and
shall not be construed against or in favor of any Party, regardless of which Party drafted this Agreement or any provision hereof.

 

(i) Counterparts.
This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original and all of which together shall
constitute one and the same instrument. True and accurate copies of this Agreement shall have the same force and effect as original hereof.

 

(j) Third
Party Beneficiaries. Each and all of the Company Parties are intended third-party beneficiaries of this Agreement and shall have
standing to enforce this Agreement in accordance with its terms.

 

(k) Survival.
Sections 3, 4(c), 5, 6, 7, 8, 9, 10, 11, and 12 of this Agreement (the “Surviving Provisions”) shall survive the termination
of the Consulting Services hereunder and shall remain in full force and effect following such termination.

 

[Signature
page follows]

 

    	6

     

    

 

The
Company and the Consultant have duly executed this Agreement:

 

	 	ONCOCYE
    CORPORATION
	 	 
	 	By:	/s/ Andy Arno
	 	Name:
    	Andy
    Arno
	 	Title:	Chairman
    of the Board of Directors
	 	Date:	12/19/2022

 

	 	DOUGLAS
    ROSS
	 	 
	 	Signature:	/s/
    Douglas Ross
	 	 
	 	Date:	12/19/2022

 

    	7

     

    

 

APPENDIX
A

 

Consulting
Services

 

Consultant
shall devote an average of 10 hours per week to discharge the Consulting Services contemplated hereby, including the provision of services
to facilitate the transition of responsibility of the Chief Science Officer role, as may be reasonably required by the person(s) identified
in Section 2 of the Consulting Agreement.

 

Appendix
A to Consulting Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]